KRT19-specific Antibody
Rabbit Polyclonal
Catalog number: 16858-1-AP
Ask a question about this product click here
Loading price...
Applications
| Tested applications | ELISA, WB, IHC |
| Cited applications | |
| Species specificity | human; other species not tested. |
| Cited species | |
| Positive WB detected in | HepG2 cells, human liver tissue |
| Positive IHC detected in | human lung cancer |
| Recommended dilution | WB: 1:200-1:2000 IHC: 1:20-1:200 |
Application key: WB = Western blotting, IHC = Immunohistochemistry, IF = Immunofluorescence,
IP = Immunoprecipitation
IP = Immunoprecipitation
Images
HepG2 cells were subjected to SDS PAGE followed by western blot with 16858-1-AP(KRT19-specific Antibody) at dilution of 1:800
Immunohistochemistry of paraffin-embedded human lung cancer using 16858-1-AP(KRT19-specific Antibody) at Dilution 1:50 (under 10x lens)
Immunohistochemistry of paraffin-embedded human lung cancer using 16858-1-AP(KRT19-specific Antibody) at Dilution 1:50 (under 40x lens)
Product Information
| Source | Rabbit | Purification method | Antigen affinity purification |
| Isotype | IgG | Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3. Store at -20oC. |
Immunogen Information
| Immunogen | Peptide | Full name | keratin 19 |
|
Calculated molecular weight |
44kd |
Observed molecular
weight |
40kd |
|
GenBank accession number |
NM_002276 | Gene ID (NCBI) | 3880 |
| Gene symbol | KRT19 | Synonyms | CK19; K19; K1CS; MGC15366 |
Background
Keratins are a large family of proteins that form the intermediate filament cytoskeleton of epithelial cells, which are classified into two major sequence types. Type I keratins are a group of acidic intermediate filament proteins, including K9–K23, and the hair keratins Ha1–Ha8. Type II keratins are the basic or neutral courterparts to the acidic type I keratins, including K1–K8, and the hair keratins, Hb1–Hb6. Keratin 19 is a type I cytokeratin. It is a biochemical marker of skin stem cells in vivo and in vitro. This antibody is specifically against KRT19. |
